Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients (AZTlowdose)
This study is currently recruiting participants.
Verified February 2012 by University Hospital, Geneva
Sponsor:
University Hospital, Geneva
Information provided by (Responsible Party):
Rougemont Mathieu, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01540240
First received: February 22, 2012
Last updated: February 27, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |